These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19336663)

  • 1. Combination treatment with normobaric hyperoxia and cilostazol protects mice against focal cerebral ischemia-induced neuronal damage better than each treatment alone.
    Nonaka Y; Koumura A; Hyakkoku K; Shimazawa M; Yoshimura S; Iwama T; Hara H
    J Pharmacol Exp Ther; 2009 Jul; 330(1):13-22. PubMed ID: 19336663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination effects of normobaric hyperoxia and edaravone on focal cerebral ischemia-induced neuronal damage in mice.
    Nonaka Y; Shimazawa M; Yoshimura S; Iwama T; Hara H
    Neurosci Lett; 2008 Aug; 441(2):224-8. PubMed ID: 18577423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilostazol, a phosphodiesterase 3 inhibitor, protects mice against acute and late ischemic brain injuries.
    Ye YL; Shi WZ; Zhang WP; Wang ML; Zhou Y; Fang SH; Liu LY; Zhang Q; Yu YP; Wei EQ
    Eur J Pharmacol; 2007 Feb; 557(1):23-31. PubMed ID: 17161838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cilostazol protects against hemorrhagic transformation in mice transient focal cerebral ischemia-induced brain damage.
    Nonaka Y; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H
    Neurosci Lett; 2009 Mar; 452(2):156-61. PubMed ID: 19383431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An oral administration of cilostazol before focal ischemia reduces the infarct volume with delayed cerebral blood flow increase in rats.
    Yuzawa I; Yamada M; Fujii K
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):281-6. PubMed ID: 18755408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia.
    Hase Y; Okamoto Y; Fujita Y; Kitamura A; Nakabayashi H; Ito H; Maki T; Washida K; Takahashi R; Ihara M
    Exp Neurol; 2012 Jan; 233(1):523-33. PubMed ID: 22173318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normobaric hyperoxia delays perfusion/diffusion mismatch evolution, reduces infarct volume, and differentially affects neuronal cell death pathways after suture middle cerebral artery occlusion in rats.
    Henninger N; Bouley J; Nelligan JM; Sicard KM; Fisher M
    J Cereb Blood Flow Metab; 2007 Sep; 27(9):1632-42. PubMed ID: 17311078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilostazol attenuates ischemic brain injury and enhances neurogenesis in the subventricular zone of adult mice after transient focal cerebral ischemia.
    Tanaka Y; Tanaka R; Liu M; Hattori N; Urabe T
    Neuroscience; 2010 Dec; 171(4):1367-76. PubMed ID: 20933581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostazol reduces ischemic brain damage partly by inducing metallothionein-1 and -2.
    Wakida K; Morimoto N; Shimazawa M; Hozumi I; Nagase H; Inuzuka T; Hara H
    Brain Res; 2006 Oct; 1116(1):187-93. PubMed ID: 16952340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial synergistic effects of concurrent treatment with cilostazol and probucol against focal cerebral ischemic injury in rats.
    Park SY; Lee JH; Kim CD; Rhim BY; Hong KW; Lee WS
    Brain Res; 2007 Jul; 1157():112-20. PubMed ID: 17521620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinatorial effect of probucol and cilostazol in focal ischemic mice with hypercholesterolemia.
    Kim JH; Park SH; Bae SS; Hong KW; Kim YD; Park KP; Choi BT; Shin HK
    J Pharmacol Exp Ther; 2011 Aug; 338(2):451-7. PubMed ID: 21546537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of cilostazol are mediated by multiple mechanisms in a mouse model of permanent focal ischemia.
    Shichinohe H; Tan C; Abumiya T; Nakayama N; Kazumata K; Hokari M; Houkin K; Kuroda S
    Brain Res; 2015 Mar; 1602():53-61. PubMed ID: 25617822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed hyperbaric oxygenation is more effective than early prolonged normobaric hyperoxia in experimental focal cerebral ischemia.
    Beynon C; Sun L; Marti HH; Heiland S; Veltkamp R
    Neurosci Lett; 2007 Oct; 425(3):141-5. PubMed ID: 17850964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cilostazol and aspirin pre-treatment against subsequent transient focal cerebral ischemia in rat.
    Toda Y; Katsura K; Saito M; Inaba T; Sakurazawa M; Katayama Y
    Neurol Res; 2014 Nov; 36(11):1011-9. PubMed ID: 24836463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normobaric Hyperoxia Extends Neuro- and Vaso-Protection of N-Acetylcysteine in Transient Focal Ischemia.
    Liu Y; Liu WC; Sun Y; Shen X; Wang X; Shu H; Pan R; Liu CF; Liu W; Liu KJ; Jin X
    Mol Neurobiol; 2017 Jul; 54(5):3418-3427. PubMed ID: 27177548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.
    Yang Y; Li Q; Shuaib A
    Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo normobaric hyperoxia preconditioning induces different degrees of antioxidant enzymes activities in rat brain tissue.
    Bigdeli MR; Rasoulian B; Meratan AA
    Eur J Pharmacol; 2009 Jun; 611(1-3):22-9. PubMed ID: 19303405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection by cilostazol, a phosphodiesterase type 3 inhibitor, against apoptotic white matter changes in rat after chronic cerebral hypoperfusion.
    Lee JH; Park SY; Shin YW; Hong KW; Kim CD; Sung SM; Kim KY; Lee WS
    Brain Res; 2006 Apr; 1082(1):182-91. PubMed ID: 16516167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normobaric hyperoxia combined with minocycline provides greater neuroprotection than either alone in transient focal cerebral ischemia.
    Jin X; Liu J; Liu KJ; Rosenberg GA; Yang Y; Liu W
    Exp Neurol; 2013 Feb; 240():9-16. PubMed ID: 23195595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of isoflurane and caspase 8 inhibition results in sustained neuroprotection in rats subject to focal cerebral ischemia.
    Inoue S; Davis DP; Drummond JC; Cole DJ; Patel PM
    Anesth Analg; 2006 May; 102(5):1548-55. PubMed ID: 16632840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.